Front month cotton prices ended the Friday session off the highs, though had kept 1 to 23 poitn gains for the bell. The March contract finished on a net 81 point loss for the week. The Dec contract closed the first trade week of the new year a net 7...
Nearby corn prices were another 4 ¾ to 5 ¾ cents weaker on Friday completing the week a net 10 ½ cents lower for March. That was also a new contract low. Weekly data from CFTC had the managed money spec funds closing longs and adding shorts for a 19.7k...
Soybean futures were another 11 ¼ to 13 ¼ cents weaker on Friday, leading the front months to new lows for the move. March beans finished at a net 41 ¾ cent loss on the day. Soymeal futures ended the session with 1.5% to 3.3% losses, led by the in-deliver...
Shares of SoFi Technologies (NASDAQ: SOFI) fell 16.6% this week, according to data provided by S&P Global Market Intelligence, after a noted Wall Street analyst downgraded the banking and fintech services stock.
Shares of Walgreens Boots Aliance (NASDAQ: WBA) fell as much as 10% earlier this week, according to data provided by S&P Global Market Intelligence, then settled down 4% as of Friday's close after a historic dividend cut overshadowed reasonably solid quarterly results from th
Investment management firms, stock exchanges and the U.S. Securities and Exchange Commission on Friday discussed final wording changes on filings for spot bitcoin ETFs, a step that could lead to U.S. approval of the funds for the first time next week, sources familiar with the matter said.
Skittish investors drove down the price of a host of altcoins this week, due in no small part to an alarming report from a crypto services firm. This analysis speculated that the hoped-for regulatory approval of the first spot cryptocurrency exchange-traded funds (ETFs) is not go
Sarepta Therapeutics convinced a Delaware federal court on Friday to end a patent lawsuit filed by biotech company Regenxbio and the University of Pennsylvania over Sarepta's treatment for Duchenne muscular dystrophy (DMD).
Symbotic (NASDAQ: SYM) fell substantially over the last week of trading. The robotics specialist's share price ended the period down 15.5% from where it was at the previous week's market close, according to data from S&P Global Market Intelligence.
What you need to know… The S&P 500 Index ($SPX ) (SPY ) on Friday closed up +0.18%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.07%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.15%. Stocks on Friday posted modest gains in volatile...
An article about Fisker (NYSE: FSR) published after market hours Thursday on an influential online tech news site caused quite a stir among investors at the end of the week. As a result, the electric vehicle (EV) manufacturer's share price took a nearly 9% hit on Friday, during a
Are you considering a new position in Ally Financial (NYSE: ALLY)? It's not a crazy idea. The stock's dirt cheap right now, priced at less than ten times its trailing-per-share earnings and less than 9 times its profits projected for the year ahead. The dividend yield of 3.5% isn
According to Zillow, the typical home value in the United States is about $350,091. Depending on the home, the state, the neighborhood, and the market, however, that amount can vary widely. I'm a...
Pinpointing the exact amount that you need to save to retire comfortably is a difficult task -- and reaching that goal may be even harder. According to a recent survey conducted by Schwab Retirement...
A recent GOBankingRates survey shows that nine out of 10 people have checking accounts. But despite the familiarity, the question of how much, exactly, to keep in one remains a personal finance...
The United States said on Friday it was troubled by comments from Burundian President Evariste Ndayishimiye, who last week called on citizens of the small African country to stone gay people.
The boards of directors of the Federal Reserve's 12 regional banks, including their leadership ranks, got less diverse by gender and race in 2024, going against a years-long trend, data released by the U.S. central bank on Friday showed.
Sarepta Therapeutics convinced a Delaware federal court on Friday to end a patent lawsuit filed by biotech company Regenxbio and the University of Pennsylvania over Sarepta's treatment for Duchenne muscular dystrophy (DMD).
While the holidays tend to be a reflective time, the definitive flip of the calendar into a new year can inspire you to set your sights high. Go to the gym more. Be on your phone less. And — if you’re like many Americans — get your credit card debt under control, once and for...
Checked
28 minutes 20 seconds ago
This feed is responsible for generating the rss feed related to the topic META